Patrick Mauro Investment Advisor INC. raised its position in CME Group Inc. (NASDAQ:CME – Free Report) by 3.6% in the 3rd quarter, HoldingsChannel.com reports. The fund owned 54,600 shares of the financial services provider’s stock after acquiring an additional 1,898 shares during the quarter. CME Group comprises approximately 4.6% of Patrick Mauro Investment Advisor INC.’s holdings, making the stock its 4th largest position. Patrick Mauro Investment Advisor INC.’s holdings in CME Group were worth $14,304,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds also recently bought and sold shares of the business. BlackRock Inc. acquired a new position in shares of CME Group in the second quarter worth $6,749,965,000. Bank of America Corp DE grew its position in shares of CME Group by 39.1% during the first quarter. Bank of America Corp DE now owns 4,019,944 shares of the financial services provider’s stock worth $1,187,290,000 after buying an additional 1,130,587 shares in the last quarter. Bank of New York Mellon Corp acquired a new position in shares of CME Group during the second quarter worth about $867,313,000. Alphabet Inc. acquired a new position in shares of CME Group during the second quarter worth about $769,376,000. Finally, Mitsubishi UFJ Asset Management Co. Ltd. purchased a new stake in shares of CME Group during the second quarter worth approximately $629,771,000. 87.75% of the stock is currently owned by hedge funds and other institutional investors.
Wall Street Analyst Weigh In
CME has been the topic of several analyst reports. Weiss Ratings raised shares of CME Group from a “buy (b)” rating to a “buy (b+)” rating in a report on Friday. Wall Street Zen upgraded shares of CME Group from a “sell” rating to a “hold” rating in a research report on Saturday, October 31st. UBS Group boosted their target price on CME Group from $270.00 to $310.00 and gave the company a “neutral” rating in a report on Thursday, October 22nd. CLSA set a $367.00 price target on shares of CME Group in a research note on Thursday, October 22nd. Finally, JPMorgan Chase & Co. raised shares of CME Group from an “underweight” rating to an “overweight” rating and set a $367.00 price target for the company in a report on Thursday, October 22nd. Ten investment analysts have rated the stock with a Buy rating, six have issued a Hold rating and two have assigned a Sell rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus target price of $314.44.
Get Our Latest Report on CME Group
CME Group Stock Performance
Shares of CME stock opened at $317.97 on Monday. The business’s fifty day moving average price is $286.01 and its 200 day moving average price is $281.54. The firm has a market capitalization of $113.81 billion, a PE ratio of 26.08, a P/E/G ratio of 3.88 and a beta of 0.15. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.02 and a quick ratio of 1.02. CME Group Inc. has a 1-year low of $218.31 and a 1-year high of $329.16.
CME Group (NASDAQ:CME – Get Free Report) last released its earnings results on Wednesday, October 21st. The financial services provider reported $3.02 EPS for the quarter, beating analysts’ consensus estimates of $2.99 by $0.03. The company had revenue of $1.74 billion during the quarter, compared to the consensus estimate of $1.71 billion. CME Group had a return on equity of 16.23% and a net margin of 63.33%. CME Group’s quarterly revenue was up 10.6% compared to the same quarter last year. During the same quarter last year, the company earned $2.68 earnings per share. As a group, sell-side analysts forecast that CME Group Inc. will post 12.35 EPS for the current fiscal year.
CME Group Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Wednesday, December 30th. Stockholders of record on Friday, December 11th will be issued a $1.30 dividend. This represents a $5.20 dividend on an annualized basis and a dividend yield of 1.6%. The ex-dividend date is Friday, December 11th. CME Group’s dividend payout ratio (DPR) is currently 42.66%.
Insider Transactions at CME Group
In other CME Group news, Director Daniel G. Kaye sold 532 shares of the company’s stock in a transaction dated Monday, November 9th. The shares were sold at an average price of $304.17, for a total transaction of $161,818.44. Following the transaction, the director directly owned 4,313 shares in the company, valued at approximately $1,311,885.21. This represents a 10.98% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, Director Howard J. Siegel sold 2,000 shares of the stock in a transaction dated Monday, November 2nd. The shares were sold at an average price of $303.00, for a total transaction of $606,000.00. Following the completion of the transaction, the director directly owned 19,873 shares of the company’s stock, valued at approximately $6,021,519. This trade represents a 9.14% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last three months, insiders have sold 33,511 shares of company stock valued at $9,714,580. 0.30% of the stock is owned by company insiders.
CME Group Profile
CME Group operates a global marketplace for derivatives and other financial products. Through its exchanges—CME, CBOT, NYMEX and COMEX—it offers futures and options contracts tied to interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The company also provides clearing and settlement services, market data and related products. Its electronic trading platform, CME Globex, supports access to its markets by participants around the world, alongside its open-outcry and privately negotiated trading services.
Recommended Stories
- Five stocks we like better than CME Group
- Fossil Just Turned a Profit—Can Its Comeback Survive the Holidays?
- Beaming Up the Backlog: AeroVironment Lands $405M Laser Deal
- Intuitive Machines’ Business Is Taking Off—Will Its Stock Follow?
- The Next Big Thing May Not Be One Thing: Inside Lazard’s Megatrends ETF
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME – Free Report).
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.
